chr16-84169989-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_178452.6(DNAAF1):​c.1161C>G​(p.Asp387Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0348 in 1,613,912 control chromosomes in the GnomAD database, including 1,829 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. D387D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.064 ( 594 hom., cov: 33)
Exomes 𝑓: 0.032 ( 1235 hom. )

Consequence

DNAAF1
NM_178452.6 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -2.10

Publications

11 publications found
Variant links:
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017419457).
BP6
Variant 16-84169989-C-G is Benign according to our data. Variant chr16-84169989-C-G is described in ClinVar as Benign. ClinVar VariationId is 226571.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.159 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF1NM_178452.6 linkc.1161C>G p.Asp387Glu missense_variant Exon 8 of 12 ENST00000378553.10 NP_848547.4 Q8NEP3-1A0A140VJN4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF1ENST00000378553.10 linkc.1161C>G p.Asp387Glu missense_variant Exon 8 of 12 1 NM_178452.6 ENSP00000367815.5 Q8NEP3-1

Frequencies

GnomAD3 genomes
AF:
0.0639
AC:
9728
AN:
152192
Hom.:
595
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.162
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.0378
Gnomad ASJ
AF:
0.0383
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0500
Gnomad FIN
AF:
0.00442
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0273
Gnomad OTH
AF:
0.0531
GnomAD2 exomes
AF:
0.0363
AC:
9121
AN:
251318
AF XY:
0.0357
show subpopulations
Gnomad AFR exome
AF:
0.162
Gnomad AMR exome
AF:
0.0241
Gnomad ASJ exome
AF:
0.0340
Gnomad EAS exome
AF:
0.000326
Gnomad FIN exome
AF:
0.00545
Gnomad NFE exome
AF:
0.0282
Gnomad OTH exome
AF:
0.0431
GnomAD4 exome
AF:
0.0317
AC:
46349
AN:
1461602
Hom.:
1235
Cov.:
32
AF XY:
0.0321
AC XY:
23324
AN XY:
727116
show subpopulations
African (AFR)
AF:
0.167
AC:
5595
AN:
33472
American (AMR)
AF:
0.0260
AC:
1164
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0359
AC:
939
AN:
26136
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39700
South Asian (SAS)
AF:
0.0541
AC:
4662
AN:
86248
European-Finnish (FIN)
AF:
0.00623
AC:
333
AN:
53416
Middle Eastern (MID)
AF:
0.0878
AC:
487
AN:
5546
European-Non Finnish (NFE)
AF:
0.0276
AC:
30693
AN:
1111998
Other (OTH)
AF:
0.0409
AC:
2468
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
3163
6325
9488
12650
15813
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1242
2484
3726
4968
6210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0639
AC:
9736
AN:
152310
Hom.:
594
Cov.:
33
AF XY:
0.0630
AC XY:
4690
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.162
AC:
6736
AN:
41540
American (AMR)
AF:
0.0377
AC:
577
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0383
AC:
133
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.0490
AC:
237
AN:
4832
European-Finnish (FIN)
AF:
0.00442
AC:
47
AN:
10626
Middle Eastern (MID)
AF:
0.0986
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
0.0273
AC:
1859
AN:
68032
Other (OTH)
AF:
0.0521
AC:
110
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
452
903
1355
1806
2258
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0264
Hom.:
58
Bravo
AF:
0.0710
TwinsUK
AF:
0.0259
AC:
96
ALSPAC
AF:
0.0254
AC:
98
ESP6500AA
AF:
0.154
AC:
678
ESP6500EA
AF:
0.0316
AC:
272
ExAC
AF:
0.0392
AC:
4760
Asia WGS
AF:
0.0290
AC:
101
AN:
3478
EpiCase
AF:
0.0344
EpiControl
AF:
0.0331

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
May 05, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Asp387Glu in exon 8 of DNAAF1: This variant is not expected to have clinical s ignificance because it has been identified in 16.3% (1690/10388) of African chro mosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs36062234). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 28, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Primary ciliary dyskinesia 13 Benign:2
Oct 21, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Mar 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 31213628) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.0030
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0032
T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.81
FATHMM_MKL
Benign
0.065
N
LIST_S2
Benign
0.55
T
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
-2.1
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.088
Sift
Benign
0.070
T
Sift4G
Benign
0.17
T
Polyphen
0.95
P
Vest4
0.071
MutPred
0.13
Gain of glycosylation at K386 (P = 0.2387);
MPC
0.098
ClinPred
0.039
T
GERP RS
-1.1
Varity_R
0.048
gMVP
0.11
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs36062234; hg19: chr16-84203595; API